Triptoreline Injection 3.75/11.25/22.5 mg/vial

Triptoreline Injection 3.75/11.25/22.5 mg/vial
Product Description

White to off white color lyophilized powder filled in clear tubular glass vial. Triptorelin is a GnRH agonist indicated for the palliative treatment of advanced prostate cancer. Triptorelin is a synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin reversibly represses gonadotropin secretion.

BIOZENTA ONCOLOGY

  • IN
  • 2023
    On CPHI since
  • 4
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)

BIOZENTA ONCOLOGY

  • IN
  • 2023
    On CPHI since
  • 4
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)

More Products from BIOZENTA ONCOLOGY (4)

  • Abiraterone Acetate Tablets USP 250/500 mg

    Product Abiraterone Acetate Tablets USP 250/500 mg

    A White to off-white coloured elongated shaped biconvex uncoated tablet having break line on one side and plain on another side. Abiraterone Acetate treats prostate cancer that has spread to other parts of the body.
  • Goserlin Acetate Injection 3.6 mg/10.8 mg/vial

    Product Goserlin Acetate Injection 3.6 mg/10.8 mg/vial

    A White or almost white Lyophilized powder filled in 5 ml clear tubular glass vial. Goserlin Injection is used for the treatment of prostate cancer in men and for breast cancer, endometriosis and uterine fibroids in women. In combination with some other medicine, it is used in the treatment of female infe...
  • Idarubicin Hydrochloride Injection 5/10/20 mg/vial ( As Lyophilized)

    Product Idarubicin Hydrochloride Injection 5/10/20 mg/vial ( As Lyophilized)

    A reddish orange colored lyophilized cake filled in 5 ml amber glass vial. Idarubicin is an anthracycline antineoplastic agent used to treat acute myeloid leukemia (AML) in adults.
  • Treosulfan For Injection 1/5 mg/vial

    Product Treosulfan For Injection 1/5 mg/vial

    Vials containing 1 g or 5 g treosulfan. Powder for solution for injection/infusion. A white crystalline odourless powder. Treosulfan is indicated for the palliative treatment of epithelial ovarian cancer.

BIOZENTA ONCOLOGY resources (1)

  • Brochure Company Brochure

    We are manufacturer and exporter of Oncology/Anticancer, General Range and Critical Care Finish Formulations. The formulation facility is WHO GMP certified and has an ultramodern, well equipped, dedicated setup for manufacturing of Liquid Injectables, Lyophilized Injectables, Prefilled Syringes, Tablets and Capsules.